The 2025 Forbes Healthcare Summit will convene the world's most influential leaders in healthcare, medicine and science.
The latest announcement is out from Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H ( ($HK:1276) ). Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Big Pharma is panicking. The Trump administration’s probe into international pharmaceutical pricing and its executive order ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback